SYNAPSE HEALTH APPOINTS SHAW RIETKERK CHIEF OPERATING OFFICER
SKOKIE, Ill., Feb. 17, 2025 /PRNewswire/ -- Synapse Health, a leader in advancing the durable medical equipment (DME) industry toward value-based care, today announced the appointment of Shaw Rietkerk as Chief Operating Officer. In this role, Rietkerk will lead Synapse's core operations and revenue cycle management, bringing best-in-class service for patients, prescribers and supplier partners.
Before joining Synapse, Rietkerk served as Chief Operating Officer of AdaptHealth where he was instrumental in the company's rapid growth, optimizing operations and revenue cycle management through technology implementation and process improvement. Prior to Adapt, Rietkerk served as EVP & General Manager at Brightree.
'Shaw is a respected industry veteran who understands the challenges our supplier partners face in a rapidly evolving DME landscape. His unique experience with both Adapt and Brightree gives him rare insight into the complexities suppliers of all sizes face in transitioning to value-based care. With Shaw leading our operations, we will strengthen and expand our collaboration with partners to ensure their success within the Synapse model,' said Cory Roberts, co-founder of Synapse Health.
Rietkerk joins Synapse during a period of significant growth, as the company continues making material investments in technology, AI-driven automation, and key system integrations to streamline workflows for suppliers and prescribers while enhancing its self-service patient experience. During his tenure at Adapt, Rietkerk was a supplier partner in Synapse's initial risk-based model launch, gaining firsthand insight into how Synapse could strengthen suppliers in the movement towards value-based care.
'Joining Synapse felt like a once-in-a-lifetime opportunity to drive meaningful change in an industry where I have spent much of my career. As a former Synapse supplier, I understand the potential of aligning incentives and reducing administrative burdens for suppliers, patients, and referral sources. I am excited to work with our incredible network of partners—many of whom are longtime colleagues and friends—to drive the industry forward by addressing the financial and operational complexities of change together,' said Rietkerk.
Learn more about Synapse Health's impact at synapsehealth.com.
Media Contact:
SOURCE Synapse Health
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
2 days ago
- Business Insider
Barclays Remains a Buy on Cadence Bank (CADE)
In a report released on July 25, Jared Shaw from Barclays maintained a Buy rating on Cadence Bank, with a price target of $43.00. The company's shares closed last Friday at $36.42. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Shaw is a 3-star analyst with an average return of 1.1% and a 53.28% success rate. Shaw covers the Financial sector, focusing on stocks such as UMB Financial, Cadence Bank, and BankUnited. In addition to Barclays, Cadence Bank also received a Buy from Morgan Stanley's Manan Gosalia in a report issued on July 25. However, on July 24, RBC Capital maintained a Hold rating on Cadence Bank (NYSE: CADE). Based on Cadence Bank's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $683.78 million and a net profit of $133.22 million. In comparison, last year the company earned a revenue of $720.9 million and had a net profit of $116.98 million
Business Insider
2 days ago
- Business Insider
Pinnacle Financial Partners (PNFP) Receives a Buy from Barclays
Barclays analyst Jared Shaw maintained a Buy rating on Pinnacle Financial Partners on July 25 and set a price target of $125.00. The company's shares closed last Friday at $91.56. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Shaw is a 3-star analyst with an average return of 1.1% and a 53.28% success rate. Shaw covers the Financial sector, focusing on stocks such as UMB Financial, Cadence Bank, and BankUnited. In addition to Barclays, Pinnacle Financial Partners also received a Buy from Truist Financial's John McDonald CFA in a report issued on July 25. However, on July 26, TR | OpenAI – 4o downgraded Pinnacle Financial Partners (NASDAQ: PNFP) to a Hold. The company has a one-year high of $131.91 and a one-year low of $81.57. Currently, Pinnacle Financial Partners has an average volume of 673.6K. Based on the recent corporate insider activity of 56 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PNFP in relation to earlier this year. Most recently, in May 2025, Robert A. Jr. Mccabe, the CHAIRMAN of PNFP sold 50,589.00 shares for a total of $5,326,515.81.
Business Insider
2 days ago
- Business Insider
Barclays Keeps Their Buy Rating on Synovus (SNV)
In a report released on July 25, Jared Shaw from Barclays maintained a Buy rating on Synovus, with a price target of $65.00. The company's shares closed last Friday at $49.61. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Shaw is a 3-star analyst with an average return of 1.1% and a 53.28% success rate. Shaw covers the Financial sector, focusing on stocks such as UMB Financial, Cadence Bank, and BankUnited. In addition to Barclays, Synovus also received a Buy from TR | OpenAI – 4o's Wes Branchor in a report issued on July 26. However, on July 25, Wells Fargo downgraded Synovus (NYSE: SNV) to a Hold. The company has a one-year high of $61.06 and a one-year low of $35.94. Currently, Synovus has an average volume of 1.47M.
